Back to all studies
RecruitingEUCTR 2021-000350-26

A double blind, randomized, placebo-controlled, adaptive 24-week Phase IIb trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia....

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

SchizophreniaDrug
In plain English

Key information made simple

What the source confirms

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

What should you check before joining?

Check the official protocol for eligibility, treatment, visits and assessments. If recruitment is listed, confirm with the team that a specific centre is still accepting participants before taking any next step.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View the historical EU CTR record (opens in a new tab)
  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Recruiting
Enrollment listed in the registry
Not clearly listed
Sponsor
Oryzon Genomics, S.A.
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Bulgaria, Poland, Romania, ...
Age range
Not clearly listed
Official registry ID
EUCTR 2021-000350-26
Official title
A double blind, randomized, placebo-controlled, adaptive 24-week Phase IIb trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia....

Check recruitment and locations

EU CTR and CTIS records checked by HopeStage on . Registry information can change. Always confirm availability with the research team.

This study transferred to CTIS. HopeStage uses that newer record for the displayed status. A country's status does not guarantee that an individual site accepts participants.

View the historical EU CTR record (opens in a new tab)View the current CTIS record (opens in a new tab)
Current CTIS country statuses
Historical EU CTR country statuses

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Bulgaria · 11 sites
  • Multiprofile Hospital For Active Treatment Dr. Hristo Stambolski EOOD — Department of Psychiatry
    Kazanlik
    Site status: Not listed — confirm with the team
  • State Psychiatric Hospital Lovech — First Men's Ward Women's Ward
    Lovech
    Site status: Not listed — confirm with the team
  • State Psychiatric Saint Ivan Rilski Hospital — Department of general psychiatry of closed-type for adult men and for adult woman
    Novi Iskir
    Site status: Not listed — confirm with the team
  • Higya–DCC OOD — Psychiatry
    Pazardzhik
    Site status: Not listed — confirm with the team
  • University Multiprofile Hospital For Active Treatment Dr. Georgi Stranski EAD — First Psychiatric Clinic
    Pleven
    Site status: Not listed — confirm with the team
  • Outpatient Clinic for Indiv. Practice for Spec.Med. Care in Psychiatry-Dr.Madlena Dimitrova Borisova — Psychiatry
    Razgrad
    Site status: Not listed — confirm with the team
  • Center For Mental Health Ruse EOOD — Women's and Men's department for persons with severe mental disorders.Department "inpatient daycare"
    Ruse
    Site status: Not listed — confirm with the team
  • MBAL Dr. Ivan Seliminski Sliven AD — Department of Psychiatry
    Sliven
    Site status: Not listed — confirm with the team
  • Medical Center Intermedica Ltd. — Psychiatry
    Sofia
    Site status: Not listed — confirm with the team
  • Medical Center Hera EOOD — Psychiatry
    Sofiya
    Site status: Not listed — confirm with the team
  • Diagnostics-Consultancy Center Mladost M Varna OOD — Psychiatric office
    Varna
    Site status: Not listed — confirm with the team
Poland · 5 sites
  • Centrum Badan Klinicznych Pi-House Sp. z o.o. — Psychiatria
    Gdansk
    Country status: Not Yet Recruiting
  • Instytut Naukowo-Badawczy Sp. z o.o. — Psychiatria
    Lublin
    Country status: Not Yet Recruiting
  • Nowy Szpital w Olkuszu — Psychiatria
    Olkusz
    Country status: Not Yet Recruiting
  • Centrum Medyczne Hcp Sp. z o.o. — Psychiatria
    Poznan
    Country status: Not Yet Recruiting
  • Clinhouse Sp. z o.o. — Psychiatria
    Zabrze
    Country status: Not Yet Recruiting
Romania · 6 sites
  • Spitalul Clinic De Psihiatrie Prof.Dr.Alexandru Obregia — Psihiatrie
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul Clinic De Psihiatrie Prof.Dr.Alexandru Obregia — Psihiatrie
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul Clinic Judetean De Urgenta Cluj — Psihiatrie
    Cluj-Napoca
    Site status: Not listed — confirm with the team
  • Medicover S.R.L. — Psihiatrie
    Jassi
    Site status: Not listed — confirm with the team
  • Psihoconcept Med S.R.L. — Psihiatrie
    Selimbar
    Site status: Not listed — confirm with the team
  • Spitalul Clinic De Psihiatrie Dr. Gheorghe Preda Sibiu — Psihiatrie
    Sibiu
    Site status: Not listed — confirm with the team
Slovakia · 3 sites
  • Epamed s.r.o. — Psychiatry
    Kosice - Zapad
    Site status: Not listed — confirm with the team
  • Mentum s.r.o. — Psychiatry
    Stare Mesto
    Site status: Not listed — confirm with the team
  • Crystal Comfort s.r.o. — Psychiatry
    Vranov Nad Toplou
    Site status: Not listed — confirm with the team
Spain · 16 sites
  • Hospital Universitario Fundacion Alcorcon — Psiquiatría
    Alcorcon
    Site status: Not listed — confirm with the team
  • Hospital Clinic De Barcelona — Psiquiatría
    Barcelona
    Site status: Not listed — confirm with the team
  • Hospital De La Santa Creu I Sant Pau — Psiquiatría
    Barcelona
    Site status: Not listed — confirm with the team
  • Hospital Del Mar — Psiquiatría
    Barcelona
    Site status: Not listed — confirm with the team
  • Hospital Universitari Vall D Hebron — Psiquiatría
    Barcelona
    Site status: Not listed — confirm with the team
  • Hospital Universitario De Burgos — Psiquiatría
    Burgos
    Site status: Not listed — confirm with the team
  • Hospital General Universitario De Elche — Psiquiatría
    Elche
    Site status: Not listed — confirm with the team
  • Hospital Clinico San Carlos — Psiquiatría
    Madrid
    Site status: Not listed — confirm with the team
  • Hospital Universitario General De Villalba — Psiquiatría
    Madrid
    Site status: Not listed — confirm with the team
  • Hospital Quironsalud Malaga — Psiquiatría
    Malaga
    Site status: Not listed — confirm with the team
  • CENTRO DE SALUD MENTAL I - LA ERIA - OVIEDO — Psiquiatría
    Oviedo
    Site status: Not listed — confirm with the team
  • Clinica Universidad De Navarra — Psiquiatría
    Pamplona
    Site status: Not listed — confirm with the team
  • University Hospital Virgen Del Rocio S.L. — Psiquiatría
    Sevilla
    Site status: Not listed — confirm with the team
  • Hospital Universitario De Torrejon — Psiquiatría
    Torrejon De Ardoz
    Site status: Not listed — confirm with the team
  • Complexo Hospitalario Universitario De Vigo — Psiquiatría
    Vigo
    Site status: Not listed — confirm with the team
  • Complejo Asistencial De Zamora Hospital Provincial De Zamora — Psiquiatría
    Zamora
    Site status: Not listed — confirm with the team

Want help reviewing this study?

Loading the security check...
Study ID: EUCTR 2021-000350-26. We help you review the study, but cannot decide medical eligibility.
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What does the official source confirm?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Is this study recruiting?

The public registry lists this study as recruiting. Individual sites may have different statuses. The research team must confirm whether a site is open and whether you meet the criteria.

How can I check the participation requirements?

Check the official protocol for the criteria, treatment and planned assessments. The research team must confirm visits, risks, open centres and your eligibility.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me